Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Eli Lilly and Company has introduced Axiron (testosterone) topical solution, a prescription medication for adult males with low or no testosterone, in US market.
Subscribe to our email newsletter
The company has received the US Food and Drug Administration approval for Axiron on 23 November 2010.
Eli Lilly said the study results demonstrated that Axiron helped in restoring testosterone levels to within the normal range in most men.
University of California Medicine clinical trial investigator Ronald Swerdloff said currently, healthcare professionals and patients have access to topical testosterone treatment options that are applied to various areas of the skin.
"Axiron offers a new application method for patients to apply testosterone to the underarm using an applicator," Swerdloff said.